Budunova IV - Search Results

1

Synephrine and Its Derivative Compound A: Common and Specific Biological Effects.

Dodonova SA, Zhidkova EM, Kryukov AA, Valiev TT, Kirsanov KI, Kulikov EP, Budunova IV, Yakubovskaya MG, Lesovaya EA. Dodonova SA, et al. Among authors: budunova iv. Int J Mol Sci. 2023 Dec 15;24(24):17537. doi: 10.3390/ijms242417537. Int J Mol Sci. 2023. PMID: 38139366 Free PMC article. Review.

2

Roles Played by Stress-Induced Pathways in Driving Ethnic Heterogeneity for Inflammatory Skin Diseases.

Jamerson TA, Li Q, Sreeskandarajan S, Budunova IV, He Z, Kang J, Gudjonsson JE, Patrick MT, Tsoi LC. Jamerson TA, et al. Among authors: budunova iv. Front Immunol. 2022 Apr 28;13:845655. doi: 10.3389/fimmu.2022.845655. eCollection 2022. Front Immunol. 2022. PMID: 35572606 Free PMC article. Review.

3

The long winding road to the safer glucocorticoid receptor (GR) targeting therapies.

Lesovaya EA, Chudakova D, Baida G, Zhidkova EM, Kirsanov KI, Yakubovskaya MG, Budunova IV. Lesovaya EA, et al. Among authors: budunova iv. Oncotarget. 2022 Feb 18;13:408-424. doi: 10.18632/oncotarget.28191. eCollection 2022. Oncotarget. 2022. PMID: 35198100 Free PMC article. Review.

4

Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.

Lesovaya EA, Yemelyanov AY, Kirsanov KI, Yakubovskaya MG, Budunova IV. Lesovaya EA, et al. Among authors: budunova iv. Biochemistry (Mosc). 2011 Nov;76(11):1242-52. doi: 10.1134/S000629791111006X. Biochemistry (Mosc). 2011. PMID: 22117551

5

Targeting transcription factor NFkappaB: comparative analysis of proteasome and IKK inhibitors.

Gasparian AV, Guryanova OA, Chebotaev DV, Shishkin AA, Yemelyanov AY, Budunova IV. Gasparian AV, et al. Among authors: budunova iv. Cell Cycle. 2009 May 15;8(10):1559-66. doi: 10.4161/cc.8.10.8415. Epub 2009 May 13. Cell Cycle. 2009. PMID: 19372735

6

Epithelial cells in the hair follicle bulge do not contribute to epidermal regeneration after glucocorticoid-induced cutaneous atrophy.

Chebotaev DV, Yemelyanov AY, Lavker RM, Budunova IV. Chebotaev DV, et al. Among authors: budunova iv. J Invest Dermatol. 2007 Dec;127(12):2749-58. doi: 10.1038/sj.jid.5700992. Epub 2007 Jul 26. J Invest Dermatol. 2007. PMID: 17657244 Free article.

7

[Immunohistochemical study of the prostate-specific antigen in prostatic cancer].

Karseladze AI, Rytin IIe, Budunova IV. Karseladze AI, et al. Among authors: budunova iv. Arkh Patol. 2004 Mar-Apr;66(2):3-7. Arkh Patol. 2004. PMID: 15154373 Russian.

8

Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.

Budunova IV, Kowalczyk D, Pérez P, Yao YJ, Jorcano JL, Slaga TJ. Budunova IV, et al. Oncogene. 2003 May 22;22(21):3279-87. doi: 10.1038/sj.onc.1206383. Oncogene. 2003. PMID: 12761498

9

Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells.

Gasparian AV, Yao YJ, Lü J, Yemelyanov AY, Lyakh LA, Slaga TJ, Budunova IV. Gasparian AV, et al. Among authors: budunova iv. Mol Cancer Ther. 2002 Oct;1(12):1079-87. Mol Cancer Ther. 2002. PMID: 12481431

10

The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells.

Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, Slaga TJ, Budunova IV. Gasparian AV, et al. Among authors: budunova iv. J Cell Sci. 2002 Jan 1;115(Pt 1):141-51. doi: 10.1242/jcs.115.1.141. J Cell Sci. 2002. PMID: 11801732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page